Stryker Announces Acquisition of Inari Medical, Inc.

Details

for $80 per share in cash, totaling approximately $4.9 billion. The acquisition, which is expected to close by the end of Q1 2025, will expand Stryker's portfolio in the peripheral vascular segment, particularly for venous thromboembolism (VTE) treatments.

Items reported

Exhibits (2)

About Stryker Corporation

Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.